Creative Biogene Launches Novel Plasmid DNA Production for Genetic & Biotech Research

SHIRLEY, NY - Apr 16, 2015 - Creative Biogene, a leading manufacturer and provider of genomics and proteomics products and services for academic and governmental research institutes, pharmaceutical and biotechnology industry, today announced the launch of newly updated plasmid DNA production service for genetic & biotech research.

As is known that plasmid is a small DNA molecule within a cell, which is parted from a chromosomal DNA and can replicate alone. On the one hand, plasmid DNAs are taken into practice for multiplying and expression of certain genes. As a result, they can be used as vital tools in genetics and biotechnology labs. On the other hand, however, plasmids are commonly used to generate a lot of proteins from the inserted gene. 

During the whole process, the first step is to select host strain and growth conditions. Then it is high-cell-density fermentation. Next the cell can be generated, and lysis and plasmid will be purified. At last, wide range of quality control testing including genomic DNA /RNA /protein contamination test, endotoxin (lipopolysaccharides) assay, restriction profile analysis, DNA Sequencing and OD260/280 readings and so on.

David Cooper, lab director of Creative Biogene, said: “We have been committed to the perfection of plasmid DNA production for many years. With the hard work of our professional experts, now Creative Biogene can provide a large number of high quality plasmid preparation services for all kinds of applications, among which research, preclinical, clinical, as well as diagnostic applications benefit most from this technology.”

It is also said that the plasmid DNA isolation service can be practical and helpful for transfection and animal studies to not only biotechnology researchers but also pharmaceutical companies,  while plasmid DNA manufacturing services are the most affordable and high-quality in a timely and professional manner. This newly developed approach includes the construction of the targeted plasmid, producing plasmids for applications both in vitro and in vivo, robust manufacturing protocols, Flexible scale even up to gram level, high standard quality control, as well as short turn-around time.

David Cooper added: “In terms of all these characteristics and benefits, the new plasmid DNA production is a cost effective and easy approach to produce a gene or the protein... The more we study on it, the better we can benefit from it in future in life science field.”

For more related information, please visit http://www.creative-biogene.com/Services/Plasmid-DNA-Production-Service.html. This is written by Amy Collins of Creative Biogene.